Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

BTRC Antikörper (N-Term)

BTRC Reaktivität: Human, Maus, Ratte WB, ELISA, IHC, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN6260326
  • Target Alle BTRC Antikörper anzeigen
    BTRC (beta-Transducin Repeat Containing (BTRC))
    Bindungsspezifität
    • 9
    • 8
    • 6
    • 5
    • 4
    • 4
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    N-Term
    Reaktivität
    • 44
    • 15
    • 11
    • 3
    • 3
    • 3
    • 3
    • 2
    • 1
    • 1
    Human, Maus, Ratte
    Wirt
    • 43
    • 5
    Kaninchen
    Klonalität
    • 43
    • 5
    Polyklonal
    Konjugat
    • 21
    • 6
    • 6
    • 5
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser BTRC Antikörper ist unkonjugiert
    Applikation
    • 28
    • 23
    • 19
    • 16
    • 6
    • 4
    • 3
    • 1
    • 1
    • 1
    Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF), Immunocytochemistry (ICC)
    Spezifität
    BTRC Antibody detects endogenous levels of total BTRC.
    Homologie
    Pig,Bovine,Horse,Sheep,Rabbit,Dog,Chicken,Xenopus
    Aufreinigung
    The antiserum was purified by peptide affinity chromatography using SulfoLinkTM Coupling Resin (Thermo Fisher Scientific).
    Immunogen
    A synthesized peptide derived from human BTRC, corresponding to a region within N-terminal amino acids.
    Isotyp
    IgG
    Top Product
    Discover our top product BTRC Primärantikörper
  • Applikationshinweise
    WB 1:500-1:2000, IHC 1:50-1:200, IF/ICC 1:100-1:500, ELISA(peptide) 1:20000-1:40000
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    1 mg/mL
    Buffer
    Rabbit IgG in phosphate buffered saline , pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    -20 °C
    Informationen zur Lagerung
    Store at -20 °C. Stable for 12 months from date of receipt.
    Haltbarkeit
    12 months
  • Target
    BTRC (beta-Transducin Repeat Containing (BTRC))
    Andere Bezeichnung
    BTRC (BTRC Produkte)
    Synonyme
    BTRC antikoerper, Beta-TrCP antikoerper, betaTrCP antikoerper, btrcp antikoerper, btrcp1 antikoerper, fbw1a antikoerper, fbxw1 antikoerper, fbxw1a antikoerper, fwd1 antikoerper, btrc antikoerper, beta-TrCP antikoerper, BETA-TRCP antikoerper, FBW1A antikoerper, FBXW1 antikoerper, FBXW1A antikoerper, FWD1 antikoerper, bTrCP antikoerper, bTrCP1 antikoerper, beta-TrCP1 antikoerper, btrc-a antikoerper, Beta-Trcp1 antikoerper, Fbw1a antikoerper, HOS antikoerper, Slimb antikoerper, b-TrCP antikoerper, mKIAA4123 antikoerper, beta-transducin repeat containing E3 ubiquitin protein ligase antikoerper, beta-transducin repeat containing antikoerper, beta-TrCP antikoerper, beta-transducin repeat containing E3 ubiquitin protein ligase S homeolog antikoerper, beta-transducin repeat containing protein antikoerper, BTRC antikoerper, btrc antikoerper, LOC100634006 antikoerper, Btrc antikoerper, btrc.S antikoerper
    Hintergrund

    Description: Substrate recognition component of a SCF (SKP1-CUL1-F-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. Recognizes and binds to phosphorylated target proteins (PubMed:10066435, PubMed:10497169, PubMed:10644755, PubMed:10835356, PubMed:11238952, PubMed:11359933, PubMed:11994270, PubMed:12791267, PubMed:12902344, PubMed:14603323, PubMed:14681206, PubMed:14988407, PubMed:15448698, PubMed:15917222, PubMed:16371461, PubMed:25503564, PubMed:25704143, PubMed:9859996). SCF(BTRC) mediates the ubiquitination of CTNNB1 and participates in Wnt signaling (PubMed:12077367, PubMed:12820959). SCF(BTRC) mediates the ubiquitination of phosphorylated NFKB1, ATF4, CDC25A, DLG1, FBXO5, PER1, SMAD3, SMAD4, SNAI1 and probably NFKB2 (PubMed:10835356, PubMed:11238952, PubMed:14681206, PubMed:14603323). SCF(BTRC) mediates the ubiquitination of NFKBIA, NFKBIB and NFKBIE, the degradation frees the associated NFKB1 to translocate into the nucleus and to activate transcription (PubMed:10066435, PubMed:10497169, PubMed:10644755). Ubiquitination of NFKBIA occurs at 'Lys-21' and 'Lys-22' (PubMed:10066435). SCF(BTRC) mediates the ubiquitination of CEP68, this is required for centriole separation during mitosis (PubMed:25704143, PubMed:25503564). SCF(BTRC) mediates the ubiquitination and subsequent degradation of nuclear NFE2L1 (By similarity). Has an essential role in the control of the clock-dependent transcription via degradation of phosphorylated PER1 and PER2 (PubMed:15917222). May be involved in ubiquitination and subsequent proteasomal degradation through a DBB1-CUL4 E3 ubiquitin-protein ligase. Required for activation of NFKB-mediated transcription by IL1B, MAP3K14, MAP3K1, IKBKB and TNF. Required for proteolytic processing of GLI3 (PubMed:16371461).

    Gene: BTRC

    Molekulargewicht
    69kDa
    Gen-ID
    8945
    UniProt
    Q9Y297
    Pathways
    Zellzyklus, Hedgehog Signalweg
Sie sind hier:
Kundenservice